Ventas (Ventas) ROCE % : 2.28% (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Ventas ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ventas's annualized ROCE % for the quarter that ended in Mar. 2024 was 2.28%.

Ventas ROCE % Historical Data

The historical data trend for Ventas's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventas ROCE % Chart

Ventas Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

3.87

3.61

2.20

1.79

2.32

Ventas Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															2.56	4.14	1.29	1.27	2.28

Ventas ROCE % Calculation

Ventas's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	534.276	/	( ( (24157.84 - 1576.953)	+	(24725.433 - 1182.268) )	/ 2 )
	=	534.276	/	( (22580.887	+	23543.165)	/ 2 )
	=	534.276	/	23062.026
	=	2.32 %

Ventas's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	537.556	/	( ( (24725.433 - 1182.268)	+	(24672.586 - 1159.276) )	/ 2 )
	=	537.556	/	( ( 23543.165	+	23513.31 )	/ 2 )
	=	537.556	/	23528.2375
	=	2.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Ventas (NYSE:VTR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ventas ROCE % Related Terms

Thank you for viewing the detailed overview of Ventas's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas (Ventas) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (NYSE:VTR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

VEN:Germany V1TA34:Brazil

Address

353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654

Website

https://www.ventasreit.com

Ventas owns a diversified healthcare portfolio of nearly 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of net operating income.

Executives

Walter C Rakowich	director	14100 E 35TH PL, AURORA CO 80011
Debra A Cafaro	director, officer: Chairman, President and CEO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sumit Roy	director	600 LA TERRAZA BOULEVARD, ESCONDIDO CA 92025
Michael J Embler	director	C/O NMI HOLDINGS, INC., 2100 POWELL STREET, EMERYVILLE CA 94608
Robert D. Reed	director	47 DONALD DRIVE, ORINDA CA 94563
James D Shelton	director	3901 TURTLE CREEK BLVD. #12, DALLAS TX 75219
Richard I Gilchrist	director	5950 SHERRY LANE, SUITE 700, DALLAS TX 75225
Robert F Probst	officer: EVP, CFO and Acting CAO	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Gregory R Liebbe	officer: SVP, Chief Accounting Officer	500 N. HURSTBOURNE PARKWAY, SUITE 200, LOUISVILLE KY 40222
Maurice S Smith	director	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Marguerite M Nader	director	2S601 AVENUE LA TOURS, OAK BROOK IL 60523
Carey S. Roberts	officer: EVP and GC	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
James Justin Hutchens	officer: EVP Sr Housing North America	C/O VENTAS, INC., 353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
John D. Cobb	officer: SVP & Chief Investment Officer	353 N. CLARK STREET, SUITE 3300, CHICAGO IL 60654
Sean P. Nolan	director	C/O INTERMUNE, INC., 3280 BAYSHORE BLVD., BRISBANE CA 94005